231 related articles for article (PubMed ID: 28062509)
1. Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in Mice.
Nicolaou A; Zhao Z; Northoff BH; Sass K; Herbst A; Kohlmaier A; Chalaris A; Wolfrum C; Weber C; Steffens S; Rose-John S; Teupser D; Holdt LM
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):247-257. PubMed ID: 28062509
[TBL] [Abstract][Full Text] [Related]
2. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
3. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
4. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
[TBL] [Abstract][Full Text] [Related]
5. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in
Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474
[TBL] [Abstract][Full Text] [Related]
6. The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates.
Speck N; Brandsch C; Schmidt N; Yazdekhasti N; Hirche F; Lucius R; Rimbach G; Stangl GI; Reiss K
J Nutr; 2015 Jun; 145(6):1218-26. PubMed ID: 25926412
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Superoxide Dismutase 2 Activity Induces Atherosclerotic Plaque Instability During Aging in Hyperlipidemic Mice.
Vendrov AE; Stevenson MD; Alahari S; Pan H; Wickline SA; Madamanchi NR; Runge MS
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079564
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
9. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice.
Takafuji Y; Hori M; Mizuno T; Harada-Shiba M
Cardiovasc Res; 2019 May; 115(6):1041-1051. PubMed ID: 30388208
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting Enzyme in Smooth Muscle Cells Promotes Atherosclerosis-Brief Report.
Chen X; Howatt DA; Balakrishnan A; Moorleghen JJ; Wu C; Cassis LA; Daugherty A; Lu H
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1085-9. PubMed ID: 27055902
[TBL] [Abstract][Full Text] [Related]
11. Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.
Sakai K; Nagashima S; Wakabayashi T; Tumenbayar B; Hayakawa H; Hayakawa M; Karasawa T; Ohashi K; Yamazaki H; Takei A; Takei S; Yamamuro D; Takahashi M; Yagyu H; Osuga JI; Takahashi M; Tominaga SI; Ishibashi S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2590-2600. PubMed ID: 30354246
[TBL] [Abstract][Full Text] [Related]
12. SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation.
Chen J; Cao Z; Guan J
BMC Cardiovasc Disord; 2018 Apr; 18(1):72. PubMed ID: 29703160
[TBL] [Abstract][Full Text] [Related]
13. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
14. Deletion of fibroblast activation protein provides atheroprotection.
Stein S; Weber J; Nusser-Stein S; Pahla J; Zhang HE; Mohammed SA; Oppi S; Gaul DS; Paneni F; Tailleux A; Staels B; von Meyenn F; Ruschitzka F; Gorrell MD; Lüscher TF; Matter CM
Cardiovasc Res; 2021 Mar; 117(4):1060-1069. PubMed ID: 32402085
[TBL] [Abstract][Full Text] [Related]
15. Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.
Barnes RH; Akama T; Öhman MK; Woo MS; Bahr J; Weiss SJ; Eitzman DT; Chun TH
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735290
[TBL] [Abstract][Full Text] [Related]
16. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
17. USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.
Jean-Charles PY; Wu JH; Zhang L; Kaur S; Nepliouev I; Stiber JA; Brian L; Qi R; Wertman V; Shenoy SK; Freedman NJ
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2295-2305. PubMed ID: 30354204
[TBL] [Abstract][Full Text] [Related]
18. Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis.
Arita-Okubo S; Kim-Kaneyama JR; Lei XF; Fu WG; Ohnishi K; Takeya M; Miyauchi A; Honda H; Itabe H; Miyazaki T; Miyazaki A
Cardiovasc Res; 2015 Mar; 105(3):361-71. PubMed ID: 25587044
[TBL] [Abstract][Full Text] [Related]
19. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
[TBL] [Abstract][Full Text] [Related]
20. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
